English National Opera (ENO) is set to stage its inaugural new production in its northern base, Manchester, with the Pulitzer Prize-winning opera 'Angel's Bone'. The performance marks a pivotal moment for the company as it navigates a significant relocation and strategic shift away from its traditional London home. This audacious choice of opera, which delves into the disturbing subject of human trafficking through the lens of two exploited angels, signals ENO's intention to make a bold cultural statement in its new surroundings.
The production is being mounted at the Warehouse at Aviva Studios, a vast industrial space in Manchester, known for its extensive technical capabilities, including large-scale rigging and Europe's largest lift. This setting provides a unique backdrop for the opera's stark themes, offering a departure from conventional theatre spaces. The choice of 'Angel's Bone', a contemporary American work by composer Du Yun and librettist Royce Vavrek, underscores ENO's commitment to presenting modern and challenging repertoire, aiming to engage new audiences in the North.
The move to Manchester follows a tumultuous period for ENO, which saw Arts Council England withdraw its regular funding in 2022, before subsequently offering a settlement that hinged on the company's relocation outside London. This decision sparked considerable debate within the arts community, with concerns raised about the future of opera in the capital and the practicalities of moving a major cultural institution. The government, through the Department for Culture, Media and Sport, supported the Arts Council's strategy, emphasising a desire to rebalance cultural investment across the UK.
For the creators of 'Angel's Bone', bringing the opera to the UK with ENO represents a significant artistic opportunity. The work's challenging narrative, which has been described by some as shocking, aims to provoke thought and discussion on difficult societal issues. The creative team has been working closely with ENO's ensemble and technical crews to adapt the production to the unique scale and character of the Manchester venue, promising an immersive and impactful experience for attendees.
The performance in Manchester is not merely a single event but a crucial step in ENO's long-term plan to establish a substantial presence in the North of England. While a smaller London presence will be maintained, the company's primary operational base and much of its artistic output are expected to transition to Manchester over the coming years. This strategy aims to broaden access to opera, foster new talent, and contribute to the cultural regeneration of the region, aligning with the government's 'levelling up' agenda.
The success of 'Angel's Bone' will be closely watched as an indicator of ENO's ability to adapt to its new environment and connect with northern audiences. The company hopes that by presenting innovative and relevant works, it can build a strong foundation for its future as a national opera company with a distinct northern identity, while continuing its mission to make opera accessible and engaging for a diverse public.